Vault-13

5AM Venture Management, LLC

SAN FRANCISCO, CA · CIK 1799883 · 13F filing filed 2022-08-15

SEC-registered investment adviser since 2021 · limited liability company

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
San Francisco, CA (main office)United States United Statesabout 8
Boston, MAUnited States United States7
New York, NYUnited States United States3

US visa salary filings

Job titleFilingsMedianRange
Senior Research AnalystNew York, NY 1 $350,000

Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: 5AM Venture Management, LLC.

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$404.2m reported value -11.7% vs Q1 2022
21positions
80.0%in top 10
2 new 1 added 2 reduced 0 sold out vs Q1 2022

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CINCOR PHARMA INC COM COM 4,337,646 $81.7m20.22% 20.22% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 4.3m, Q2 2022 4.3m
2 ENTRADA THERAPEUTICS INC COM TRDA TRDA 4,408,379 $53.7m13.28% 13.28% UnchangedShares held: Q3 2021 0, Q4 2021 4.4m, Q1 2022 4.4m, Q2 2022 4.4m
3 VOR BIOPHARMA INC COM COM 6,361,723 $31.6m7.82% 7.82% UnchangedShares held: Q3 2021 6.7m, Q4 2021 6.4m, Q1 2022 6.4m, Q2 2022 6.4m
4 PEAR THERAPEUTICS INC CLASS A COM CLASS A COM 18,631,771 $28.7m7.10% 7.10% UnchangedShares held: Q3 2021 0, Q4 2021 18.6m, Q1 2022 18.6m, Q2 2022 18.6m
5 RALLYBIO CORP COM COM 3,730,724 $28.2m6.97% 6.97% ReducedShares held: Q3 2021 4.2m, Q4 2021 4.2m, Q1 2022 4.0m, Q2 2022 3.7m -250.0k -250,000 -6.3%
6 IMPEL NEUROPHARMA INC COM COM 2,884,791 $26.9m6.65% 6.65% UnchangedShares held: Q3 2021 2.9m, Q4 2021 2.9m, Q1 2022 2.9m, Q2 2022 2.9m
7 AKOUOS INC COM COM 4,135,784 $19.4m4.80% 4.80% UnchangedShares held: Q3 2021 4.1m, Q4 2021 4.1m, Q1 2022 4.1m, Q2 2022 4.1m
8 IDEAYA BIOSCIENCES INC COM IDYA IDYA 1,398,066 $19.3m4.77% 4.77% UnchangedShares held: Q3 2021 1.4m, Q4 2021 1.4m, Q1 2022 1.4m, Q2 2022 1.4m
9 SCPHARMACEUTICALS INC COM SCPH SCPH 3,561,474 $17.2m4.25% 4.25% ReducedShares held: Q3 2021 3.8m, Q4 2021 3.8m, Q1 2022 3.8m, Q2 2022 3.6m -270.0k -270,000 -7.0%
10 ARVINAS INC COM ARVN ARVN 400,000 $16.8m4.17% 4.17% UnchangedShares held: Q3 2021 400.0k, Q4 2021 400.0k, Q1 2022 400.0k, Q2 2022 400.0k
11 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 862,286 $16.1m3.98% 3.98% UnchangedShares held: Q3 2021 1.4m, Q4 2021 862.3k, Q1 2022 862.3k, Q2 2022 862.3k
12 PHARVARIS N V COM PHVS PHVS 587,600 $13.0m3.21% 3.21% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 587.6k
13 COGENT BIOSCIENCES INC COM COGT COGT 1,129,200 $10.2m2.52% 2.52% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 711.4k, Q2 2022 1.1m +417.8k +417,788 58.7%
14 IVERIC BIO INC COM OPHT OPHT 1,027,874 $9.9m2.45% 2.45% UnchangedShares held: Q3 2021 770.0k, Q4 2021 643.2k, Q1 2022 1.0m, Q2 2022 1.0m
15 HOMOLOGY MEDICINES INC COM FIXX FIXX 4,535,919 $8.9m2.21% 2.21% UnchangedShares held: Q3 2021 4.5m, Q4 2021 4.5m, Q1 2022 4.5m, Q2 2022 4.5m
16 AVIDITY BIOSCIENCES INC COM RNA RNA 390,555 $5.7m1.40% 1.40% UnchangedShares held: Q3 2021 555.6k, Q4 2021 390.6k, Q1 2022 390.6k, Q2 2022 390.6k
17 JANUX THERAPEUTICS INC COM JANX JANX 446,266 $5.4m1.35% 1.35% UnchangedShares held: Q3 2021 446.3k, Q4 2021 446.3k, Q1 2022 446.3k, Q2 2022 446.3k
18 PROMETHEUS BIOSCIENCES INC COM COM 182,370 $5.1m1.27% 1.27% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 182.4k
19 5 01 ACQUISITION CORP COM CL A COM CL A 365,126 $3.6m0.89% 0.89% UnchangedShares held: Q3 2021 365.1k, Q4 2021 365.1k, Q1 2022 365.1k, Q2 2022 365.1k
20 CABALETTA BIO INC COM CABA CABA 2,064,263 $2.2m0.54% 0.54% UnchangedShares held: Q3 2021 2.4m, Q4 2021 2.1m, Q1 2022 2.1m, Q2 2022 2.1m
21 CIDARA THERAPEUTICS INC COM COM 1,134,511 $554.0k0.14% 0.14% UnchangedShares held: Q3 2021 1.1m, Q4 2021 1.1m, Q1 2022 1.1m, Q2 2022 1.1m